miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis
These results collectively indicate that targeting the miR-512-3p/RPS6KA2 regulatory axis may offer a novel and effective strategy for overcoming cisplatin resistance in ovarian cancer.
Authors
- Jianhua Wu (ORCID: https://orcid.org/0000-0001-6093-599X)
- Zhou Liu (ORCID: https://orcid.org/0000-0002-5698-3945)
- Xiaoying Hu (ORCID: https://orcid.org/0000-0003-4862-3621)
- Sihong Wang (ORCID: https://orcid.org/0000-0003-1398-3360)
- Huang Chen (ORCID: https://orcid.org/0000-0003-4233-292X)
- Lei Peng (ORCID: https://orcid.org/0009-0002-3171-3137)
Institutions
- Shanghai University of Medicine and Health Sciences (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-12-04
- DOI
- https://doi.org/10.32604/or.2025.070542
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00